Status:
ACTIVE_NOT_RECRUITING
A Prospective Incident Study of Arrhythmias in Hypertrophic Cardiomyopathy
Lead Sponsor:
Mayo Clinic
Collaborating Sponsors:
Medtronic
Conditions:
Hypertrophic Cardiomyopathy
Eligibility:
All Genders
18+ years
Brief Summary
The purpose of this research study is to understand more about various heart rhythms (electrical problems) in persons with hypertrophic cardiomyopathy with and without sleep apnea.
Detailed Description
Adult patients with hypertrophic cardiomyopathy and without known atrial fibrillation or pacemaker/implantable cardiac defibrillation will undergo implantable loop recorder implantation. No direct int...
Eligibility Criteria
Inclusion
- Currently or previously enrolled in 17-003514 and 16-009474
- Adults age \>18 years-old with a diagnosis of hypertrophic cardiomyopathy
- Both sexes
- Able to consent
Exclusion
- Vulnerable study population
- Known atrial fibrillation or flutter (with the exception of post-operative atrial fibrillation)
- Pacemaker/ICD implantation
- Pregnancy
Key Trial Info
Start Date :
November 5 2019
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
December 1 2027
Estimated Enrollment :
260 Patients enrolled
Trial Details
Trial ID
NCT04112290
Start Date
November 5 2019
End Date
December 1 2027
Last Update
February 3 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Mayo Clinic
Rochester, Minnesota, United States, 55905